BioHealth News Archive
CHIPS Act Authorizes Unprecedented Support for Tech Transfer
The arc of the technology transfer profession can be tied to the Bayh-Dole Act of 1980 in the United States and similar enabling legislation…
Read More
Ellume COVID test plant in Frederick starting to add automation to manufacturing | Coronavirus | fredericknewspost.com
Five months after the Australian-based biopharmaceutical company Ellume opened its first U.S. location in Frederick, the facility is scaling up its production of at-home…
Read More
Alexandria – 940 CLOPPER ROAD – GAITHERSBURG, MARYLAND – AVAILABLE 1Q23 – 8,867 RSF OF LABORATORY/OFFICE SPACE
TENANT AMENITIES • 8,867 RSF lab/office suite available 1Q23 • Dedicated suite entry • Energy efficient HVAC • Loading dock • Ample parking •…
Read More
BioBuzz: BioHealth Capital Region Forum Crab Trap Winners: Where Are They Now?
The BioHealth Capital Region Forum and Investment Conference are right around the corner on September 20th and 21st, 2022, respectively. And that means great networking opportunities, engaging…
Read More
BARDA Director Gary L. Disbrow, Ph.D., Joins Rich Bendis on the BioTalk Podcast
Gary L. Disbrow, Ph.D., Director of the Biomedical Advanced Research and Development Authority (BARDA), visits BioTalk to discuss his career, advancing research, development, and…
Read More
Johns Hopkins spinout Emocha Health closes $6.2M series A for video-based medication adherence
Emocha Health, a Johns Hopkins University spinout tackling medication adherence with an asynchronous video platform, has announced a $6.2 million series A round led by…
Read More
What does #USPVerified mean?
What does #USPVerified mean? It means that you can trust that what's on the label is what's in the bottle. The USP Verified Mark…
Read More
Immunomic Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ITI-3000 pDNA Vaccine for the Treatment of Merkel Cell Carcinoma Member Discounts – Maryland Tech Council
ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP (Lysosome Associated Membrane Protein)-mediated nucleic acid-based immunotherapy, today…
Read More
IPO market in a ‘wait-and-see period,’ EY Americas IPO leader says
EY Americas IPO Leader Rachel Gerring joins Yahoo Finance Live to discuss the U.S. IPO market, navigating through recessionary fears, inflation, supply chain woes,…
Read MoreU.S. Department of Commerce Announces Winners of American Rescue Plan $500 Million Good Jobs Challenge to Expand Employment Opportunities | U.S. Economic Development Administration
WASHINGTON – Today, U.S. Secretary of Commerce Gina Raimondo announced grant awards to 32 industry-led workforce training partnerships across the country as part of…
Read More
Johns Hopkins spinout Emocha Health closes $6.2M series A for video-based medication adherence | Fierce Healthcare
Emocha Health, a Johns Hopkins University spinout tackling medication adherence with an asynchronous video platform, has announced a $6.2 million series A round led by…
Read More
Emergent BioSolutions unveils 7th pandemic CDMO contract, this time for Humanigen’s late-stage antibody hopeful | Fierce Pharma
Manufacturing powerhouse Emergent BioSolutions unveiled its seventh COVID-19 CDMO tie-up Monday, this time to help crank out Humanigen’s late-stage antibody hopeful lenzilumab. Emergent will…
Read More
“BioTalk with Rich Bendis” Podcast Featured in BioBuzz Podcasts to Follow Now
In a job market that’s become increasingly competitive and employer-driven, it’s imperative for both active and passive job candidates to do their homework. Understanding…
Read More
REGENXBIO Announces Intention to File a Biologics License Application Using the Accelerated Approval Pathway for RGX-121, an AAV Therapeutic for the Treatment of MPS II
FDA will consider an accelerated approval pathway for RGX-121; BLA filing expected in 2024 Pivotal program is active and enrolling patients RGX-121 is a…
Read More